The Medical Letter on Drugs and Therapeutics
ADVANCE
RELEASE
ARTICLE
October 10, 2024
View Complete Issue         Table of Contents 2019 
An OTC Gel for Erectile Dysfunction (Eroxon)
Subscribers: Log in to read full article.  Not a subscriber?  Subscribe or purchase article.
An OTC Gel for Erectile Dysfunction (Eroxon)
October 10, 2024 (Issue: 5089)
The FDA has authorized over-the-counter (OTC) sale of a nonmedicated alcohol-based gel (Eroxon – Futura) for treatment of erectile dysfunction (ED) in males ≥22 years old. Eroxon is the only FDA-approved OTC and topical treatment for erectile...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this article?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App
  • FREE online per issue CME/CE
Purchase this article:
Title: An OTC Gel for Erectile Dysfunction (Eroxon)
Article code: 5089a
 Electronic, downloadable article - $45


Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.